Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia

Vipul Shukla, Ashima Shukla, Shantaram S Joshi, Runqing Lu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Molecular pathogenesis of Chronic Lymphocytic Leukemia (CLL) is not fully elucidated. Genome wide association studies have linked Interferon Regulatory Factor 4 (IRF4) to the development of CLL. We recently established a causal relationship between low levels of IRF4 and development of CLL. However, the molecular mechanism through which IRF4 suppresses CLL development remains unclear. Deregulation of Notch signaling pathway has been identified as one of the most recurrent molecular anomalies in the pathogenesis of CLL. Yet, the role of Notch signaling as well as its regulation during CLL development remains poorly understood. Previously, we demonstrated that IRF4 deficient mice expressing immunoglobulin heavy chain Vh11 (IRF4-/-Vh11) developed spontaneous CLL with complete penetrance. In this study, we show that elevated Notch2 expression and the resulting hyperactivation of Notch signaling are common features of IRF4-/-Vh11 CLL cells. Our studies further reveal that Notch signaling is indispensable for CLL development in the IRF4-/-Vh11 mice. Moreover, we identify E3 ubiquitin ligase Nedd4, which targets Notch for degradation, as a direct target of IRF4 in CLL cells and their precursors. Collectively, our studies provide the first in vivo evidence for an essential role of Notch signaling in the development of CLL and establish IRF4 as a critical regulator of Notch signaling during CLL development.

Original languageEnglish (US)
Pages (from-to)41081-41094
Number of pages14
JournalOncotarget
Volume7
Issue number27
DOIs
StatePublished - May 25 2016

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
interferon regulatory factor-4
Immunoglobulin Heavy Chains
Ubiquitin-Protein Ligases
Penetrance
Genome-Wide Association Study

Keywords

  • B1 cells
  • CLL
  • IRF4
  • Notch signaling

ASJC Scopus subject areas

  • Oncology

Cite this

Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia. / Shukla, Vipul; Shukla, Ashima; Joshi, Shantaram S; Lu, Runqing.

In: Oncotarget, Vol. 7, No. 27, 25.05.2016, p. 41081-41094.

Research output: Contribution to journalArticle

@article{6c6b5704d9f140098067b5eff6bd65e4,
title = "Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia",
abstract = "Molecular pathogenesis of Chronic Lymphocytic Leukemia (CLL) is not fully elucidated. Genome wide association studies have linked Interferon Regulatory Factor 4 (IRF4) to the development of CLL. We recently established a causal relationship between low levels of IRF4 and development of CLL. However, the molecular mechanism through which IRF4 suppresses CLL development remains unclear. Deregulation of Notch signaling pathway has been identified as one of the most recurrent molecular anomalies in the pathogenesis of CLL. Yet, the role of Notch signaling as well as its regulation during CLL development remains poorly understood. Previously, we demonstrated that IRF4 deficient mice expressing immunoglobulin heavy chain Vh11 (IRF4-/-Vh11) developed spontaneous CLL with complete penetrance. In this study, we show that elevated Notch2 expression and the resulting hyperactivation of Notch signaling are common features of IRF4-/-Vh11 CLL cells. Our studies further reveal that Notch signaling is indispensable for CLL development in the IRF4-/-Vh11 mice. Moreover, we identify E3 ubiquitin ligase Nedd4, which targets Notch for degradation, as a direct target of IRF4 in CLL cells and their precursors. Collectively, our studies provide the first in vivo evidence for an essential role of Notch signaling in the development of CLL and establish IRF4 as a critical regulator of Notch signaling during CLL development.",
keywords = "B1 cells, CLL, IRF4, Notch signaling",
author = "Vipul Shukla and Ashima Shukla and Joshi, {Shantaram S} and Runqing Lu",
year = "2016",
month = "5",
day = "25",
doi = "10.18632/oncotarget.9596",
language = "English (US)",
volume = "7",
pages = "41081--41094",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "27",

}

TY - JOUR

T1 - Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia

AU - Shukla, Vipul

AU - Shukla, Ashima

AU - Joshi, Shantaram S

AU - Lu, Runqing

PY - 2016/5/25

Y1 - 2016/5/25

N2 - Molecular pathogenesis of Chronic Lymphocytic Leukemia (CLL) is not fully elucidated. Genome wide association studies have linked Interferon Regulatory Factor 4 (IRF4) to the development of CLL. We recently established a causal relationship between low levels of IRF4 and development of CLL. However, the molecular mechanism through which IRF4 suppresses CLL development remains unclear. Deregulation of Notch signaling pathway has been identified as one of the most recurrent molecular anomalies in the pathogenesis of CLL. Yet, the role of Notch signaling as well as its regulation during CLL development remains poorly understood. Previously, we demonstrated that IRF4 deficient mice expressing immunoglobulin heavy chain Vh11 (IRF4-/-Vh11) developed spontaneous CLL with complete penetrance. In this study, we show that elevated Notch2 expression and the resulting hyperactivation of Notch signaling are common features of IRF4-/-Vh11 CLL cells. Our studies further reveal that Notch signaling is indispensable for CLL development in the IRF4-/-Vh11 mice. Moreover, we identify E3 ubiquitin ligase Nedd4, which targets Notch for degradation, as a direct target of IRF4 in CLL cells and their precursors. Collectively, our studies provide the first in vivo evidence for an essential role of Notch signaling in the development of CLL and establish IRF4 as a critical regulator of Notch signaling during CLL development.

AB - Molecular pathogenesis of Chronic Lymphocytic Leukemia (CLL) is not fully elucidated. Genome wide association studies have linked Interferon Regulatory Factor 4 (IRF4) to the development of CLL. We recently established a causal relationship between low levels of IRF4 and development of CLL. However, the molecular mechanism through which IRF4 suppresses CLL development remains unclear. Deregulation of Notch signaling pathway has been identified as one of the most recurrent molecular anomalies in the pathogenesis of CLL. Yet, the role of Notch signaling as well as its regulation during CLL development remains poorly understood. Previously, we demonstrated that IRF4 deficient mice expressing immunoglobulin heavy chain Vh11 (IRF4-/-Vh11) developed spontaneous CLL with complete penetrance. In this study, we show that elevated Notch2 expression and the resulting hyperactivation of Notch signaling are common features of IRF4-/-Vh11 CLL cells. Our studies further reveal that Notch signaling is indispensable for CLL development in the IRF4-/-Vh11 mice. Moreover, we identify E3 ubiquitin ligase Nedd4, which targets Notch for degradation, as a direct target of IRF4 in CLL cells and their precursors. Collectively, our studies provide the first in vivo evidence for an essential role of Notch signaling in the development of CLL and establish IRF4 as a critical regulator of Notch signaling during CLL development.

KW - B1 cells

KW - CLL

KW - IRF4

KW - Notch signaling

UR - http://www.scopus.com/inward/record.url?scp=85016091426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016091426&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.9596

DO - 10.18632/oncotarget.9596

M3 - Article

C2 - 27232759

AN - SCOPUS:85016091426

VL - 7

SP - 41081

EP - 41094

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 27

ER -